US Map / Kentucky
State KY

Clinical Trials in Kentucky

Kentucky is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kentucky and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 163 actively recruiting studies with Kentucky sites out of 163 registered in total. The busiest research areas in Kentucky are Colorectal Cancer, Ovarian Cancer, Hypertension. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Louisville, SWOG Cancer Research Network. By stage, Kentucky trials break down as Phase 1 (21), Phase 2 (49), Phase 3 (59), Phase 4 (8).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
163
Recruiting Now
163
← Back to US Map
Top Conditions in Kentucky
Colorectal Cancer (4)Ovarian Cancer (3)Hypertension (3)Obesity (3)Non-small Cell Lung Cancer (3)Stage III Pancreatic Cancer AJCC v8 (3)Spinal Cord Injuries (3)Acute Myeloid Leukemia (3)Heart Failure (2)Endometrial Cancer (2)NSCLC (2)Renal Insufficiency (2)

Frequently Asked Questions — Clinical Trials in Kentucky

How many clinical trials are currently recruiting in Kentucky?
ClinicalMetric currently tracks 163 actively recruiting clinical trials with at least one location in Kentucky. The total number of registered studies—including active but not currently enrolling trials—is 163. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kentucky?
Kentucky hosts clinical trials across a broad range of medical conditions, including Colorectal Cancer, Ovarian Cancer, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kentucky serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kentucky?
To join a clinical trial in Kentucky, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kentucky maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Kentucky

NCT07213973 Phase 2
Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participant...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
40 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06857942 Phase 4
Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following In...
Condition
Psoriasis
Enrollment
200 pts
Location
United States
Sponsor
Eli Lilly and Company
View Trial →
NCT05427370 N/A
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C...
Condition
Coronary Artery Disease
Enrollment
754 pts
Location
United States, Austria, Brazil
Sponsor
Sunnybrook Health Sciences Cen
View Trial →
NCT04165070 Phase 1, Phase 2
Recruiting
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) ...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
450 pts
Location
United States, Hungary, Israel
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT01574053 N/A
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition
Huntington's Disease
Enrollment
35,000 pts
Location
United States, Argentina, Australia
Sponsor
CHDI Foundation, Inc.
View Trial →
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT07290140 N/A
Recruiting
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Condition
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Enrollment
300 pts
Location
United States
Sponsor
Airiver Medical, Inc.
View Trial →
NCT07337590 N/A
Recruiting
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Condition
Colorectal Cancer
Enrollment
80 pts
Location
United States
Sponsor
Exero Medical Ltd.
View Trial →
NCT07388524 Phase 3
Recruiting
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Preven...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
336 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05001880 Phase 2
Recruiting
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Condition
Peritoneal Malignant Mesothelioma
Enrollment
66 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04781140 Phase 4
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Chi...
Condition
Attention-Deficit/Hyperactivity Disorder
Enrollment
286 pts
Location
United States
Sponsor
Supernus Pharmaceuticals, Inc.
View Trial →
NCT06116682 Phase 2
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Co...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
88 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06499285 Phase 3
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermed...
Condition
Myelodysplastic Syndromes
Enrollment
225 pts
Location
United States, Australia, Brazil
Sponsor
Takeda
View Trial →
NCT06683378 Phase 1
Recruiting
A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Au...
Condition
Parkinson's Disease
Enrollment
24 pts
Location
United States
Sponsor
Craig van Horne, MD, PhD
View Trial →
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
View Trial →
NCT04903119 Phase 1
Recruiting
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Me...
Condition
Metastatic Melanoma
Enrollment
30 pts
Location
United States
Sponsor
Rina Plattner
View Trial →
NCT04965675 Phase 3
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Condition
Chronic Migraine in Children
Enrollment
285 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
View Trial →
NCT03339128 Phase 2
Recruiting
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bow...
Condition
Irritable Bowel Syndrome
Enrollment
95 pts
Location
United States, Bulgaria, Canada
Sponsor
AbbVie
View Trial →
NCT07169734 Phase 1, Phase 2
Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Ad...
Condition
Cervical Squamous Cell Carcinoma
Enrollment
180 pts
Location
United States, France, Hong Kong
Sponsor
Alentis Therapeutics AG
View Trial →
NCT06868212 Phase 3
Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Time...
Condition
Chronic Spontaneous Urticaria (CSU)
Enrollment
400 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05451004 Phase 3
Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Laterali...
Condition
Oropharyngeal Cancer
Enrollment
510 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06207032 N/A
Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Condition
Cancer
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Tempus AI
View Trial →
NCT06091865 Phase 3
Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and Ho...
Condition
Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment
904 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07496567 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Brazil, Colombia
Sponsor
EyeBiotech Ltd.
View Trial →
NCT05521503 N/A
Recruiting
Biopsy Collection and Repository Database
Condition
Cardiovascular Diseases
Enrollment
400 pts
Location
United States
Sponsor
Kenneth S. Campbell
View Trial →
Page 6 of 7 — 163 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology